172 related articles for article (PubMed ID: 17198869)
1. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia.
Yoshida N; Yagasaki H; Takahashi Y; Yamamoto T; Liang J; Wang Y; Tanaka M; Hama A; Nishio N; Kobayashi R; Hotta N; Asami K; Kikuta A; Fukushima T; Hirano N; Kojima S
Br J Haematol; 2008 Jul; 142(3):427-35. PubMed ID: 18537977
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients].
Mu XY; Chang H; Liu T; Gong YP; Niu T; Qin H; Ma HB; Meng WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):897-900. PubMed ID: 19950609
[TBL] [Abstract][Full Text] [Related]
4. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.
Schrezenmeier H; Hertenstein B; Wagner B; Raghavachar A; Heimpel H
Exp Hematol; 1995 Jan; 23(1):81-7. PubMed ID: 7995374
[TBL] [Abstract][Full Text] [Related]
5. Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin.
Nakao S; Takami A; Sugimori N; Ueda M; Shiobara S; Matsuda T; Mizoguchi H
Br J Haematol; 1996 Jan; 92(1):155-8. PubMed ID: 8562389
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of aplastic anemia with anti-thymocyte globulin and cyclosporine].
Ohnishi S; Nakagawa M; Kobayashi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Kasai M
Rinsho Ketsueki; 1998 Sep; 39(9):640-4. PubMed ID: 9796396
[TBL] [Abstract][Full Text] [Related]
7. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
Dubey S; Shukla P; Nityanand S
Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
[TBL] [Abstract][Full Text] [Related]
8. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
Huang YL; Huang SL; Huang K; Bao R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of aquired aplastic anemia].
Kulagin AD; Lisukov IA; Kriuchkova IV; Sizikova SA; Gilevich AV; Denisova VV; Filimonov PN; Meniaeva EV; Pronkina NV; Kozhevnikov VS; Chernykh ER; Kozlov VA
Ter Arkh; 2006; 78(11):48-54. PubMed ID: 17195527
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
11. The ancestry of the HLA-DRB1*15 allele predisposes the Mexican mestizo to the development of aplastic anemia.
Fernández-Torres J; Flores-Jiménez D; Arroyo-Pérez A; Granados J; López-Reyes A
Hum Immunol; 2012 Aug; 73(8):840-3. PubMed ID: 22580214
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Saunthararajah Y; Nakamura R; Nam JM; Robyn J; Loberiza F; Maciejewski JP; Simonis T; Molldrem J; Young NS; Barrett AJ
Blood; 2002 Sep; 100(5):1570-4. PubMed ID: 12176872
[TBL] [Abstract][Full Text] [Related]
13. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
[TBL] [Abstract][Full Text] [Related]
14. Association of aplastic anaemia and Fanconi's disease with HLA-DRB1 alleles.
Yari F; Sobhani M; Vaziri MZ; Bagheri N; Sabaghi F; Talebian A
Int J Immunogenet; 2008 Dec; 35(6):453-6. PubMed ID: 19046304
[TBL] [Abstract][Full Text] [Related]
15. Association of HLA haplotypes with paroxysmal nocturnal hemoglobinuria.
Nowak J; Mika-Witkowska R; Mendek-Czajkowska E; Rogatko-Koros M; Graczyk-Pol E; Pyl H; Klimczak A; Wojcik M; Nowak EA; Dlugokecka A; Prochorec M; Zupanska B
Transplant Proc; 2010 Oct; 42(8):3266-70. PubMed ID: 20970669
[TBL] [Abstract][Full Text] [Related]
16. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
[TBL] [Abstract][Full Text] [Related]
18. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
Song EY; Kang HJ; Shin HY; Ahn HS; Kim I; Yoon SS; Park S; Kim BK; Park MH
Hum Immunol; 2010 Jan; 71(1):88-92. PubMed ID: 19819281
[TBL] [Abstract][Full Text] [Related]
19. Paroxysmal nocturnal hemoglobinuria: significant association with specific HLA-A, -B, -C, and -DR alleles in an Italian population.
Lombardi ML; Terrazzano G; Cosentini E; Gargiulo L; Risitano A; Camerlingo R; Sica M; Aufiero D; Poggi A; Pirozzi G; Luzzatto L; Rotoli B; Notaro R; Alfinito F; Ruggiero G
Hum Immunol; 2008 Mar; 69(3):202-6. PubMed ID: 18396213
[TBL] [Abstract][Full Text] [Related]
20. The frequency of HLA class I alleles in Japanese patients with bone marrow failure.
Shichishima T; Noji H; Ikeda K; Akutsu K; Maruyama Y
Haematologica; 2006 Jun; 91(6):856-7. PubMed ID: 16704965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
